TAMOXIFEN - NEW MEMBRANE-MEDIATED MECHANISMS OF ACTION AND THERAPEUTIC ADVANCES

被引：116

作者：

WISEMAN, H ^{[1
]}

机构：

[1] ROYAL FREE HOSP,SCH MED,DEPT BIOCHEM,LONDON NW3 2PF,ENGLAND

来源：

TRENDS IN PHARMACOLOGICAL SCIENCES | 1994年 / 15卷 / 03期

关键词：

D O I：

10.1016/0165-6147(94)90283-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Tamoxifen protects membranes and lipoprotein particles against oxidative damage. This antioxidant action is likely to contribute to the observed cardioprotective action of tamoxifen and supports the use of this compound in treating and even preventing breast cancer. Membrane-mediated mechanisms of tamoxifen action, through a putative modulation of membrane fluidity, are likely to play an important role in its anticancer action and its ability to reverse multidrug resistance, and could also lead to clinical uses as an anti-Candida and anti-viral agent. In this review, Helen Wiseman discusses the interaction of tamoxifen with membranes and lipoprotein particles, and considers the possible clinical implications.

引用

页码：83 / 89

页数：7

共 45 条

[1]

BEGGS WH, 1993, RES COMMUN CHEM PATH, V80, P125

[2] ANTIVIRAL EFFECT OF TAMOXIFEN [J].

BENSON, JR ;

BAUM, M .

LANCET, 1993, 341 (8855) :1288-1288

[3]

BERMAN E, 1991, BLOOD, V77, P818

[4] INFLUENCE OF DI-PHENYLETHYLENE AND TRI-PHENYLETHYLENE ESTROGEN ANTIESTROGEN STRUCTURE ON THE MECHANISMS OF PROTEIN-KINASE-C INHIBITION AND ACTIVATION AS REVEALED BY A MULTIVARIATE-ANALYSIS [J].

BIGNON, E ;

PONS, M ;

DORE, JC ;

GILBERT, J ;

OJASOO, T ;

MIQUEL, JF ;

RAYNAUD, JP ;

DEPAULET, AC .

BIOCHEMICAL PHARMACOLOGY, 1991, 42 (07) :1373-1383

[5] DROLOXIFENE, A NEW ANTIESTROGEN IN POSTMENOPAUSAL ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS OF A DOUBLE-BLIND DOSE-FINDING PHASE-II TRIAL [J].

BRUNING, PF .

EUROPEAN JOURNAL OF CANCER, 1992, 28A (8-9) :1404-1407

[6]

BUTTA A, 1992, CANCER RES, V52, P4261

[7]

CHLEBOWSKI RT, 1993, CANCER, V72, P1032, DOI 10.1002/1097-0142(19930801)72:3+<1032::AID-CNCR2820721315>3.0.CO

[8]

2-O

[9] REDUCTION OF THE MEMBRANE FLUIDITY OF HUMAN BREAST-CANCER CELLS BY TAMOXIFEN AND 17-BETA-ESTRADIOL [J].

CLARKE, R ;

VANDENBERG, HW ;

MURPHY, RF .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (21) :1702-1705

[10] CLINICAL AND RADIOGRAPHIC RESPONSE IN A MINORITY OF PATIENTS WITH RECURRENT MALIGNANT GLIOMAS TREATED WITH HIGH-DOSE TAMOXIFEN [J].

COULDWELL, WT ;

WEISS, MH ;

DEGIORGIO, CM ;

WEINER, LP ;

HINTON, DR ;

EHRESMANN, GR ;

CONTI, PS ;

APUZZO, MLJ ;

KORNBLITH, P ;

DETRIBOLET, N ;

TAOA, M ;

LEVIN, VA ;

OLDFIELD, EH .

NEUROSURGERY, 1993, 32 (03) :485-490

← 1 2 3 4 5 →